Aviron Message Board - Msg: 5656241

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron

AVIR 3.260

+0.3%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mauser96 who wrote (354)	9/2/1998 5:07:00 PM
From: Arthur Radley	Read Replies (1) of 645

Excellent description of the issue at hand. With this novel delivery system, I guess we should have expected that the FDA would make sure of the purity of the manufacturing process. Again, and if I'm wrong please correct me, the current plant manufacturing this drug for AVIR is located in Europe. Not to say that Europeans would not have safety concerns, it behooves the FDA to make sure that any drug with this much potential of use, would be extra cautious in the manufacturing approval process that is part of any NDA application. Normally I would say this is a once in a life time buying opportunity for a new drug with great potential, but the overall market conditions give me pause. Hard to believe that AVIR is down nearly 2/3rds in the past few weeks.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next